Single Source Procurement: Cystic Fibrosis Test Kits and Reagents
Pursuant to New York State Finance Law § 163.10(b), The New York State Department of Health is presenting the following summary of relevant circumstances, and material and substantial reasons why a competitive procurement was not feasible. The Illumina MiSeqDx platform and application are the only FDA approved next generation sequencing system for in-vitro use within a clinical laboratory.
| Procurement / Program Name | Cystic Fibrosis Test Kits and Reagents |
|---|---|
| Contractor Name(s) | Illumina, Inc. |
| Contract Period | 5/23/18 - 3/31/19 |
| Contract Number | OP033850 |
